Transposon Tn7 transposes at high frequency to a specific site, attTn7, in the Escherichia coli chromosome. We devised a quantitative assay for Tn7 transposition in which Tn7-end derivatives containing the cis-acting transposition sequences of Tn7 transpose from a bacteriophage lambda vector upon infection into cells containing the Tn7-encoded transposition proteins. We used this assay to identify a 68-base-pair DNA segment containing the sequences essential for atlTn7 target activity. This segment is positioned asymmetrically with respect to the specific point of Tn7 insertion in atLln7 and lacks obvious homolog to the sequences at the ends of Tn7 which participate directly in transposition. We also show that some sequences essential for attTn7 target activity are contained within the protein-coding sequence of a bacterial gene.
Transposons are precise DNA segments which can translocate from place to place in the genome. Most procaryotic elements transpose at low frequency and show little target site specificity upon insertion into large DNA molecules such as bacterial chromosomes (for reviews, see references 22 and 41). Tn7 is a transposon which provides resistance to trimethoprim and to streptomycin and spectinomycin (3) (Fig. 1A) . Tn7 is of particular interest because it can transpose at high frequency to a specific target site. The capacity of Tn7 for high-frequency transposition to the Escherichia coli chromosome was revealed by the finding that after incompatibility exclusion of a plasmid containing Tn7 in the absence of selection for Tn7, 5'to 100% of the chromosomes contain Tn7 (2, 3, 18, 24) . Similarly, we have observed that after temperature exclusion of F'ts lac+::Tn7, about 5 to 10% of the plasmid-free cells contain chromosomal Tn7 (C. Waddell and N. L. Craig, unpublished observation). When Tn7 transposes to the E. coli chromosome, it inserts in a specific site at about min 84 called attTn7 (3, 24, 25) ; this chromosomal site is referred to hereafter as attTn784. The specific point of Tn7 insertion lies between phoS, a gene involved in phosphate transport, and g1mS, a gene involved in cell wall biosynthesis (25, 47) (Fig. 1B) . In attTn784::Tn7, the left end of Tn7 (Tn7L), which encodes its drug resistance determinants, is adjacent to phoS, and the right end of Tn7 (Tn7R), which encodes its transposition prote'ins, is adjacent to gimS (24) . Thus, Tn7 insertion into the E. coli chromosome is both site and orientation specific. Site-specific insertion of Tn7 into the chromosomes of other bacteria has also been observed; the organisms include Agrobacterium tumefaciens (19) , Vibrio species (45), Caulobacter crescentus (10) , Pseudomonas aeruginosa (6), Rhodopseudomonas capsulata (49) , Rhizobium meliloti (5), Xanthomonas campestris pv. campestris (46) , and Pseudomonas fluorescens (1).
It has previously been shown that when large E. coli chromosomal fragments containing the specific insertion point are introduced into plasmids, Tn7 inserts at high frequency into these DNA fragments in a site-and orientation-specific fashion (24, 36) , demonstrating that attTn7 activity is determined by sequences within these segments.
* Corresponding author.
In this work, we examined the functional extent of attTn7 by comparing the target activities of DNA fragments containing the specific point of Tn7 insertion and various extents of flanking sequence. We demonstrated that a small (68-basepair [bp]) DNA fragment positioned asymmetrically with respect to the specific point of Tn7 insertion has attTn7 activity; i.e., it is a target'for high-frequency, site-specific insertion of Tn7.
MATERIALS AND METHODS Media, chemicals, and enzymes. LB broth and agar were as described by Miller (30) except that 1 mg of glucosamine per ml was added to the agar. With trimethoprim, Iso-Sensitest agar (Oxoid Ltd.) was used. When used, supplements were as follows: carbenicillin, 100 ,.g/ml; chloramphenicol, 30 ,ug/ml; kanamycin', 50 or 100 jig/Ml; tetracycline, 5 jig/ml; and trimethoprim, 100 p.g/ml. DNA-modifying enzymes were obtained from commercial sources and used as recommended by the manufacturer.
Manipulation and analysis of DNA. Plasmid growth, isolation, transformation, and restriction enzyme analyses were performed as described by Maniatis et al. (27) . Cloning techniques were performed as described by Maniatis et al. (27) except that usually DNA fragments contained in slices excised from low-melting-temperature agarose gels (SeaPlaque; FMC Corp., Marine Colloids Div.) were used directly in the assembly of recombinant molecules as described by Struhl (43) . Bacteriophage lambda growth was performed as described by Maniatis et al. (27) . DNA sequence analysis was performed as described by Sanger et al. (40) , using double-stranded plasmid DNA as a template (7) . To circumvent difficulties with sequencing the potential G+C-rich stem-loop structure in attTn7, we included T4 gene 32 protein (B. Alberts, University of California, San Francisco) (33) in the sequencing reaction mixtures and used either Klenow fragment with deoxy-7-deazaguanosine triphosphate (American Bionetics) (32) Insertions of Tn7-Cm and Tn7-Km into pRM4 attTn7 were isolated by transformation of plasmid DNA isolated from strains containing attTn784::Tn7, pRM4, and pOX38::Tn7-end derivatives, selecting for Tn7-end-derivative drug resistance. The site-and orientation-specific insertion of the Tn7-end derivatives into the pRM4 attTn7 site was verified by restriction enzyme digestion (data not shown). Derivatives of phage lambda 780 (b2::hisOGD b522 c1857 Pam8O ninS) (13) that acquired the TnIO::attTn7::Tn7-end-derivative segments by homologous recombination within hisOGD were obtained by isolating tetracycline-resistant phages from phage stocks grown in NK5012(pRM4::Tn7-end-derivative) strains by using the selective plaque assay (28) . Acquisition of the Tn7-end derivatives by the phages was verified by demonstrating that lysogens of the phages also expressed Tn7-end-derivative drug resistance. Lambda RM7 is lambda 780 hisG9424::TnJO del16 de117::attTn7(-342 to +165)::Tn7 L1900 Cmr Tn7R537, and lambda KK1 is lambda 780 hisG9424: :TnJO dell6 dell7: :attTn7(-342 to + 165): :Tn7 L166 Kmr Tn7R199 (see Results for attTn7 numbering).
Lambda hop assays. A culture of cells to be assayed was grown to about 4 x 108 cells per ml in LB broth plus 0.2% maltose, concentrated by centrifugation, and suspended at 1.6 x 109 cells per ml in 0.01 M MgSO4. Phage was added to 0.1 ml of cells at a multiplicity of 0.1 per cell. The resulting 0.2-ml mixture was incubated at 37°C for 15 min, 0.8 ml of LB broth plus 0.01 M sodium citrate was added, and incubation was continued at 37°C with shaking for 60 min. Samples from the mixture (or dilutions thereof in LB broth plus 0.01 M sodium citrate) were spread on plates containing appropriate antibiotics (chloramphenicol or chloramphenicol-trimethoprim for Tn7-Cm or kanamycin or kanamycintrimethoprim for Tn7-Km), and the plates were incubated at 37°C for 1 day before counts were made.
attTn7-containing plasmids. In pAR6 (35) , the chromosomal EcoRI fragment containing the specific Tn7 insertion point is inserted into the EcoRI site of pBR322 with attTn7R adjacent to vector P-lactamase; this plasmid contains attTn7(-10,200 to +869).
We constructed the following attTn7 plasmids. For pRM1, the HpaI-HpaI fragment from pAR6 containing the specific Tn7 insertion point was inserted into the HincIl site of pUC18 with attTn7R adjacent to vector plac; this plasmid contains attTn7(-459 to +623). To construct pRM2, the TaqI-TaqI fragment from pRM1 containing the specific Tn7 insertion point was inserted into the AccI site of pUC18 with attTn7R adjacent to vector plac; this plasmid contains attTn7(-342 to +165) (Fig. 1B) . To construct pRM4, the SmaI site of pRM2 was converted to a HindIII site by linker insertion and the resulting HindIll-HindIll attTn7(-342 to + 165) fragment was inserted into the unique HindIll site of pNK217 (13) with attTn7R adjacent to vector-encoded tetracycline resistance.
To construct pKAO1-1 and pKAO1-2, the DraI-HincII fragment from pRM2 containing the specific insertion point was inserted into the HincIl site of pUC18 with attTn7R adjacent to vector plac (pKAO1-1) or with attTn7L adjacent to vector plac (pKAO1-2); these plasmids contain attTn7 (-158 to +64).
For pKAO3, the NlaIII-HincII fragment from pRM2 containing the specific insertion point was inserted into the A VOL. 170, 1988 HincII-SphI sites of pUC18 such that attTn7R is adjacent to vector plac; this plasmid contains attTn7(-52 to +64).
For pKA04-1, pKA04-2, and pKA04-3, the PvuIIattTn7(+64 to -158)-PstI fragment of pKAO1-1 was isolated and partially digested with FokI, the termini were filled in with Klenow fragment, and the fragment extending from PvuII to the FokI site distal to the specific point of Tni insertion was inserted into the SmaI site of pKO500 with attTn7L adjacent to vector galK to give pKA04-1. pKO500 (from K. McKenney, National Institutes of Health) is pKO1 (29) derivatized by replacement of the EcoRI site by a Sall linker, insertion of the 300-bp PvuII-PvuII fragment containing plac and the polylinker from ml3mpll into the Smal site of pKO1, and subsequent deletion of the plac-containing HindIII fragment to give SaIl-HindIII(polylinker)EcoRIgalK. pKA04-2 and pKA04-3 contain the EcoRI attTn7 fragment from pKA04-1 inserted into the EcoRI site of pUC19 with attTn7R adjacent to plac (pKA04-2) or with attTn7L adjacent to plac (pKA04-3). All of these plasmids contain attTn7(-25 to +64).
To construct pKA016, pEG10, and pEG11, the PvuIIattTn7(+64 to -158)-PstI fragment of pKAO1-1 was treated as described above and the fragment extending from PvuII to the FokI site proximal to the specific insertion point was inserted into the SmaI site of pKO500 with attTn7L adjacent to vector galK to give pKA016. pEG10 and pEG11 contain the SstI attTn7 fragment from pKA016 inserted into the SstI site of pKL600 with attTn7R adjacent to plac (pEG10) or with attTn7L adjacent to plac (pEG11). pKL600 (K. McKenney) is pKO1 (29) derivatized by replacement of the EcoRI site by a SalI linker, introduction of the 300-bp PvuII-PvuII fragment containing the plac promoter and polylinker from ml3mplO into the SmaI site, and introduction of a translation stop codon in place of the polylinker EcoRI site. All of these' plasmids contain attTn7(-4 to +64).
To construct pKA015, the PvuII-attTn7(+64 to -52)-PstI fragment of pKAO1-1 was treated as described above and the fragment extending from PvuII to the FokI site proximal to the specific insertion point was inserted into the SmaI site of pKO500 with attTn7R adjacent to vector gaiK; this plasmid contains attTn7(-3 to +64).
For pTC1, the EcoRI-HindIl attTn7 fragment from pRM2 was isolated and digested with MaeIII, the termini were filled in with Klenow fragment, and the MaeIII fragment containing the specific insertion point was inserted into the HincII site of pUC18 with attTn7R adjacent to vector plac; this plasmid contains attTn7(-55 to +38).
RESULTS
A small DNA segment has atiTn7 activity. In our nomenclature for attTn7, the middle base of the 5-bp chromosomal sequence duplicated upon Tn7 insertion (15, 25) is designated 0, sequences extending leftward toward phoS from the point of insertion (attTn7L) are given a minus value, and sequences extending rightward toward glmS are given a plus value (Fig. 2) . pAR6 (35) contains attTn7(-10,200 to +869), and we constructed plasmids containing the specific insertion point and various extents of flanking attTn7L and attTn7R sequences. We evaluated the capacity of these plasmids to be targets for Tn7 insertion by introducing them into recA attTn784: :Tn7 hosts and then determining the fraction of the plasmids occupied by Tn7. The fractional occupancies by Tn7 of several plasmids containing attTn7 sequences, ranging from attTn7(-10,200 to +869) (pAR6) to attTn7(-3 to +64) (pKA015), is several thousandfold higher than that of a non-attTn7 plasmid (Table 1) . We also examined the position of Tn7 insertion in these plasmids by restriction enzyme digestion and found that Tn7 inserted site and orientation specifically into the tested plasmids (data not shown). Thus, attTn7(-3 to +64) is a target for efficient siteand orientation-specific insertion of Tn7.
Quantitative assay for Tn7 transposition. Although the fractional occupancy assay described above demonstrated that sequences immediately surrounding the specific insertion point can direct insertion of Tn7, we were concerned that the observed fractional occupancies might be influenced by differences between the unoccupied and occupied plasmids other than the target activity of the attTn7 segment, such as plasmid stability and the efficiency of DNA isolation, and thus might not be an accurate reflection of the target activity of the attTn7 segment. Therefore, we developed an acute assay for Tn7 transposition. We devised a lambda hop assay (23) in which a Tn7-end derivative transposes from a replication-and integration-defective variant of bacteriophage lambda upon phage infection. The Tn7-end derivatives Tn7-Cm (18) and Tn7-Km (Arcisewska and Craig, in preparation) contain the essential cis-acting sequences for Tn7 transposition and transpose when complemented in trans by Tn7-encoded transposition proteins. We constructed phage lambda vectors containing these Tn7-end derivatives as described in Materials and Methods. Upon infection of phages carrying the Tn7-end derivatives into strains containing Tn7 in the chromosome and the attTn7-containing plasmnid pAR6, high-frequency transposition of the Tn7-end derivatives was observed (Table 2, row 7). The Tn7-end derivatives inserted into pAR6 in site-and orientation-specific fashion (data not shown). Product colonies were lambda and tetracycline sensitive and thus contained no information from the donor phage other than the Tn7-end derivative (data not shown). High-frequency transposition required Tn7 (Table 2 , rows 1 and 2) and a vacant plasmid attTn7 site (Table 2 , rows 3 to 6). (Although Tn7 in attTn784::Tn7 can transpose to the attTn7 plasmid as described above, the fraction of plasmids actually occupied by Tn7 is small, so that most of the plasmid attTn7 sites are vacant [ Table 1 ]). At low frequency (about 2 x 1O-7 transpositions per PFU), the Tn7-end derivatives do transpose from the donor phage to chromosomal sites (K. Kubo and N. L. Craig, unpublished observation). Target activity of plasmids containing various atTn7 segments. We used the Tn7 lambda hop assay to directly and quantitatively compare the attTn7 target activities of plasmids containing the specific Tn7 insertion point and various extents of flanking nucleotide sequence. We found that the target activity of attTn7(-3 to +64) (Table 2, row 22) was equivalent to that of larger segments containing the specific insertion point and more extensive flanking sequence (rows 7 to 21). These results demonstrate that the sequence information required for attTn7 target activity, i.e., to act as a target for high-frequency insertion of Tn7, is contained within attTn7(-3 to +64). We also found that a DNA segment containing less attTn7R information, attTn7(-55 to + 38), was not a reactive target for Tn7 insertion (lines 23 and 24), demonstrating that sequence information within the segment attTn7(+39 to +64) is essential for attTn7 target activity.
In these experiments, the attTn7 segment was located downstream of a strong promoter provided by the vector backbone (see Materials and Methods). We directly compared the target activity of attTn7 segments located in either orientation with respect to this external promoter, i.e., with transcription entering attTn7 from attTn7R or from attTn7L. We found that the orientation of attTn7 with respect to an external promoter does not affect its target activity (Table 2,  compare rows 11 and 12, 17 and 18, and 20 and 21) .
Insertion of Tn7-end derivatives into atfTn7 is site and orientation specific. To evaluate the insertion sites of the Tn7-end derivatives, we isolated plasmid DNA from the products of Tn7 lambda hops and analyzed it by restriction enzyme digestion. These experiments revealed that the Tn7-end derivatives inserted site and orientation specifically into the active plasmid attTn7 sites, independent of whether transcription entered attTn7 from attTn7R or from attTn7L (data not shown). Thus, sequence information within attTn7(-3 to +64) provides the fundamental characteristics of attTn7: the capacity to be a high-frequency target for the site-and orientation-specific insertion of Tn7. Nucleotide sequence of attln7 and attTn7::Tn7. Several other investigators have sequenced the attTn7 region, and the reported sequences immediately surrounding the specific insertion point differ (15, 25, 47) . We also sequenced attTn7(-52 to +64), and our results agree with those of Gay et al. (15) . We used several methods to overcome the difficulties of sequencing the G+C-rich potential stem-loop region in attTn7 (see Materials and Methods). The sequence of the attTn7 region obtained by Gay et al. (15) and by us is shown in Fig. 2 . We also sequenced a number of independent insertions of Tn7-Km into several different attTn7 segments. We sequenced both the left and right novel junctions of nine independent insertions into attTn7(-25 to +64), four in pKA04-2 and five in pKA04-3. In eight instances, duplication of the 5-bp target sequence CCCGC was observed (Fig. 2) . Lichtenstein and Brenner (25) observed the same duplication in their analysis of two independent Tn7 insertions into an attTn7-containing plasmid. In one instance, with pKA04-2, we observed duplication of the sequence CCGCT which is displaced by 1 nucleotide toward glmS from the CCCGC sequence. We also sequenced 10 independent insertions into attTn7(-4 to +64), 5 in pEG10 and 5 in pEG11. In nine instances, the target sequence CCCGC was also duplicated. In one instance, with pEG10, the sequence CCCCG which is displaced by 1 (15) and by us. The boxed bases are those duplicated upon Tn7 insertion. The underlined bases are the protein-coding sequences at the 3' end of g1mS. (Bottom) Potential secondary structure at the 3' end of gimS transcripts suggested by Gay et al. (15) . attTn7(-3 to +64) (boxed) provides attTn7 activity, and attTn7(+39 to +64) (hatched region) contains information essential to attTn7 activity.
positions of insertion were both observed under conditions in which transcription enters attTn7 from attTn7R, a condition which reflects the configuration of attTn784 (47) .
DISCUSSION
We showed that the 68-bp attTn7(-3 to +64) DNA fragment which includes the specific Tn7 insertion point and extends rightward about 65 bp contains sufficient sequence information to promote the efficient site-and orientationspecific insertion of both intact Tn7 and several Tn7-end derivatives. Our results are consistent with the hypothesis that attTn7 is contained entirely within this fragment, although we have not excluded the possibility that there are other important attTn7 sequences whose activity we artificially compensated for by examining the target activity of attTn7 fragments in multicopy plasmids. We also found that attTn7(-55 to +38) does not promote Tn7 insertion. Thus, information within attTn7(+39 to +64) is essential for attTn7 activity and at least some attTn7 information actually lies at a considerable distance from the specific insertion point. Our analysis did not establish whether the point of insertion itself is critical to attTn7 activity. It is possible that for Tn7 insertion into attTn7, the sites of specific recognition and action are distinct, as occurs with certain restriction enzymes (20) .
An interesting result of our analysis is that at least some information required for attTn7 function actually lies within the coding sequence of the glmS gene, although the specific insertion point itself is downstream of glmS (Fig. 2) . Thus, some nucleotides in this region have dual roles: they provide template information for mRNA synthesis and provide attTn7 activity. There are other nucleotide sequences which have been shown to have multiple functions; for example, the origin of phage lambda replication lies within the coding sequence of the lambda replication protein 0 (8, 14) . Specific Tn7 insertion sites have been also been observed in the chromosomes of other bacteria (1, 5, 6, 10, 19, 45, 46, 49) . One interesting possibility is that these sites share considerable sequence homology with E. coli attTn7 and that these sequences are highly conserved because they also provide information for the glmS product, an enzyme involved in an important cellular function, cell wall biosynthesis. While this manuscript was in preparation, we learned that Lichtenstein and coworkers have found that specific Tn7 insertion sites in several bacteria are adjacent to sequences homologous to the E. coli gimS terminus (C. Lichtenstein, personal communication).
As initially pointed out by Gay et al. (15) , the specific point of Tn7 insertion lies in a region of potential secondary structure: a G+C-rich stem-loop followed by T residues (Fig. 2) . This sequence motif is characteristic of both Rhoindependent transcription terminators (37) and secondary structures which stabilize the 3' ends of mRNA (17) . Gay et al. (15) showed that the 3' termini of glmS transcripts do occur in this region. By introducing the attTn7(-52 to +64) fragment into a terminator probe vector, we have shown directly that attTn7 does act as a transcription terminator (E. Gringauz, K. Orle, C. Waddell, and N. L. Craig, submitted for publication). A direct role for transcription has been implicated in other genomic rearrangements such as Saccharomyces cerevisiae mating-type switching (21) and immunoglobulin gene assembly (4, 42) and in the activation of certain origins of replication (8, 9) . We show here that attTn7 activity is independent of the direction of transcription entering attTn7. In other experiments, we have found that attTn7 segments promote efficient insertion of the Tn7-end derivatives when located in vectors which do not provide high-level transcription into the attTn7 segment (Gringauz et al., submitted). Thus, it is unlikely that transcription from gimS is a regulator of attTn7 activity. Why is attTn7 such a specific and reactive site for Tn7 insertion? There are no considerable homologies between the DNA segments which participate directly in Tn7 sitespecific insertion, i.e., attTn7 (Fig. 2) and the ends of Tn7 (15, 16, 25) . Other mobile genetic elements such as bacteriophage lambda which recognize specific target sites employ extensive structural similarities which include regions of precise DNA homology between the target site and the mobile element to direct insertion (for reviews, see references 39 and 48). We do not yet know how the ends of Tn7 specifically recognize attTn7 in the absence of obvious structural similarity between these DNA segments. One attractive hypothesis is that a protein(s) recognizes the ends of Tn7 and that this protein interacts with another protein which recognizes attTn7. Alternatively, a single protein which recognizes two different nucleotide sequences (34, 38) could mediate this interaction. Further work is required to define the nucleotides within the attTn7(-3 to +64) segment which are essential to autTn7 target activity and to determine how the ends of Tn7 recognize attTn7.
